Evidence of Person-to-Person Transmission of Oseltamivir-Resistant Pandemic Influenza A(H1N1) 2009 Virus in a Hematology Unit

被引:56
作者
Moore, Catherine
Galiano, Monica
Lackenby, Angie [7 ]
Abdelrahman, Tamer
Barnes, Rosemary [4 ]
Evans, Meirion R. [3 ,5 ]
Fegan, Christopher [2 ]
Froude, Susannah
Hastings, Mark
Knapper, Steven [6 ]
Litt, Emma [2 ]
Price, Nicola
Salmon, Roland [3 ]
Temple, Mark [3 ]
Davies, Eleri [1 ]
机构
[1] Publ Hlth Wales NHS Trust, Univ Wales Hosp, Cardiff CF14 4XW, S Glam, Wales
[2] Univ Wales Hosp, Dept Hematol, Cardiff CF4 4XW, S Glam, Wales
[3] Publ Hlth Wales NHS Trust, Ctr Communicable Dis Surveillance, Cardiff CF14 4XW, S Glam, Wales
[4] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff, S Glam, Wales
[5] Cardiff Univ, Dept Publ Hlth & Primary Care, Cardiff, S Glam, Wales
[6] Cardiff Univ, Dept Hematol, Cardiff, S Glam, Wales
[7] Hlth Protect Agcy, Ctr Infect, Div Virus Reference, Resp Virus Unit, London, England
基金
英国惠康基金;
关键词
INFECTION;
D O I
10.1093/infdis/jiq007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We describe the first confirmed person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus that occurred in a hematology unit in the United Kingdom. Eleven cases of (H1N1) 2009 virus infection were identified, of which, ten were related as shown by sequence analysis of the hemagglutinin and neuraminidase genes. H275Y analysis demonstrated that 8 of 10 case patients had oseltamivir-resistant virus, with 4 of 8 case patients infected by direct transmission of resistant virus. Zanamivir should be considered as first-line therapy for influenza in patients with lymphopenic hematological conditions and uptake of influenza vaccination encouraged to further reduce the number of susceptible individuals.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 15 条
[1]  
Ellis J, 2009, EUROSURVEILLANCE, V14
[2]   Prolonged Influenza Virus Infection during Lymphocytopenia and Frequent Detection of Drug-Resistant Viruses [J].
Gooskens, Jairo ;
Jonges, Marcel ;
Claas, Eric C. J. ;
Meijer, Adam ;
Kroes, Aloys C. M. .
JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (10) :1435-1441
[3]   Morbidity and Mortality Associated With Nosocomial Transmission of Oseltamivir-Resistant Influenza A(H1N1) Virus [J].
Gooskens, Jairo ;
Jonges, Marcel ;
Claas, Eric C. J. ;
Meijer, Adam ;
van den Broek, Peterhans J. ;
Kroes, Aloys C. M. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 301 (10) :1042-1046
[4]   Insomnia and Depression during Protective Isolation in Patients with Hematological Disorders [J].
Kunitomi, Akane ;
Iida, Hiroatsu ;
Kamiya, Yoshikazu ;
Hayashi, Mayuko ;
Suwa, Taro ;
Kanda, Junya ;
Sao, Hiroshi .
INTERNAL MEDICINE, 2010, 49 (01) :17-22
[5]  
Lackenby A, 2008, EURO SURVEILL, V13
[6]  
Lackenby A, 2008, ANTIVIR THER, V13, P809
[7]  
Mank Arno, 2003, Eur J Oncol Nurs, V7, P17, DOI 10.1054/ejon.2002.0216
[8]   Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro [J].
Nguyen, Jack T. ;
Hoopes, Justin D. ;
Le, Minh H. ;
Smee, Donald F. ;
Patick, Amy K. ;
Faix, Dennis J. ;
Blair, Patrick J. ;
de Jong, Menno D. ;
Prichard, Mark N. ;
Went, Gregory T. .
PLOS ONE, 2010, 5 (02)
[9]   MODELTEST: testing the model of DNA substitution [J].
Posada, D ;
Crandall, KA .
BIOINFORMATICS, 1998, 14 (09) :817-818
[10]   2009 H1N1 Influenza [J].
Sullivan, Seth J. ;
Jacobson, Robert M. ;
Dowdle, Walter R. ;
Poland, Gregory A. .
MAYO CLINIC PROCEEDINGS, 2010, 85 (01) :64-76